BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/18/2026 11:03:40 AM | Browse: 0 | Download: 0
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Ticagrelor vs clopidogrel on vein graft patency in patients with diabetes undergoing coronary artery bypass grafting
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Rui-Jun Yuan, Keng Zhong, Jie Lu, Xing-Li Fan, Zhi-Min Zhao, Wen-Wen Li, Jiao-Na Qiu, Guan-Xin Zhang and Qing Xue |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| The Clinical Research Special Project of Shanghai Municipal Health Commission |
No. 202240358 |
| National Natural Science Foundation of China |
No. 82470444 |
| The Funding of Basic Medical Research Project of Changhai Hospital |
No. 2023PY05 |
| Chang Jian Leading Talent Prospect of Changhai Hospital |
No. 2024CF002 |
| Demonstration of Clinical Application of Innovative Medical Devices under Shanghai High-Quality Development Plan for Science and Technology Industry |
No. 25SF1908305 |
|
| Corresponding Author |
Qing Xue, Professor, Department of Cardiovascular Surgery, Shanghai Changhai Hospital, The First Affiliated Hospital of Naval Medical University, No. 168 Changhai Road, Shanghai 200433, China. chyyxwkxq@163.com |
| Key Words |
Type 2 diabetes mellitus; Coronary artery bypass grafting; Ticagrelor; Clopidogrel; Saphenous vein graft patency |
| Core Tip |
In this retrospective cohort of patients with type 2 diabetes mellitus undergoing coronary artery bypass grafting, ticagrelor plus aspirin was associated with better 5-year saphenous vein graft patency than clopidogrel plus aspirin. No statistically significant differences in major adverse cardiovascular events or bleeding events were observed, but the study was underpowered for safety outcomes. These findings suggest a potential benefit of ticagrelor for saphenous vein graft patency in this high-risk population, warranting confirmation in prospective randomized trials. |
| Citation |
Yuan RJ, Zhong K, Lu J, Fan XL, Zhao ZM, Li WW, Qiu JN, Zhang GX, Xue Q. Ticagrelor vs clopidogrel on vein graft patency in patients with diabetes undergoing coronary artery bypass grafting. World J Diabetes 2026; In press
|
 |
Received |
|
2026-08-07 11:52 |
 |
Peer-Review Started |
|
2026-08-17 00:20 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2026-09-02 09:26 |
 |
Revised |
|
2026-09-22 07:35 |
 |
Publication Fee Transferred |
|
|
 |
Editorial Processing by Scientific Editor |
|
2026-11-11 02:44 |
 |
Final Academic Decision by Editor-in-Chief |
|
|
 |
Publication Technical Verification by Editorial Office Director |
|
2026-11-18 11:03 |
 |
Articles in Press |
|
2026-11-18 11:03 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.